pyridoxine sodium semaglutide Hidden ingredient in Ozempic and Wegovy tablets raises new gut health questions FDA issues warning about some

The announcement follows a joint investigation into the alleged unlawful manufacturing and distribution of GLP-1 and GIP medicines promoted for weight loss

Increased bowel movements or diarrhoea

As a dual GIP/GLP-1 receptor agonist, it has a broader mechanism of action, which may enhance its effectiveness in controlling glucose levels

The increase in absorbance at 470 nm was recorded over 2 min to calculate POD activity

The federal Mental Health Parity and Addiction Equity Act (MHPAEA) continues to require that BCBS plans offering mental health benefits do so on terms no more restrictive than medical or surgical benefits, and regulators have stepped up enforcement in 2026 with new auditing requirements for insurers